Propensity‐matched comparison of large‐bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real‐world experience. Issue 3 (29th May 2021)

• Record Type: Journal Article
• Authors: Medranda, Giorgio A.; Case, Brian C.; Zhang, Cheng; Rappaport, Hank; Weissman, Gaby; Bernardo, Nelson L.; Satler, Lowell F.; Ben‐Dor, Itsik; Rogers, Toby; Waksman, Ron
• Is Part Of: Catheterization and cardiovascular interventions. Volume 98:Issue 3(2021)
• Page Start: 580
• Page End: 585
• Publication Date: 2021-05-29
• Subjects: aortic valve disease -- bleeding -- closure -- complications -- percutaneous intervention -- transcatheter valve implantation -- vascular -- vascular access -- vascular complications; Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.29786
• Languages: English
• ISSNs: 1522-1946

Abstract

Abstract: Objective: Compare two large‐bore vascular closure devices (VCDs), collagen‐plug‐based MANTA and suture‐based dual Perclose ProGlide (PP), in patients undergoing contemporary transfemoral transcatheter aortic valve replacement (TAVR). Background: The SAFE MANTA IDE clinical trial demonstrated that the collagen‐plug‐based MANTA VCDs were safe and effective in closing large‐bore arteriotomies. However, data comparing this collagen‐plug‐based VCD to the suture‐based VCD in contemporary practice are sparse. Methods: This was a retrospective observational study in which we screened transfemoral (TF) TAVR patients at our institution from 2017 to 2020. Included were those whose large‐bore TF access was closed using either MANTA or PP with and without Angio‐Seal. Our primary outcome was VCD success. Additional in‐hospital outcomes included major and minor vascular complications, post‐TAVR length of stay, and mortality. Results: We screened 696 patients who underwent TAVR. Using propensity scores, we matched 124 patients who received MANTA with 124 patients who received PP. Patients had a mean age of 77.2 years, 69.0% were men, and their mean Society of Thoracic Surgeons score was 3.4%. VCD success was equivalent between VCDs (95.2% vs. 95.2%; p = 1.000). Patients had similar rates of mortality (0% vs. 0.8%; p = .316), and no patients had major vascular complications. Conclusions: In contemporary TAVR, the collagen‐plug‐based MANTA VCD appears to be as safe and effective as the suture‐based dual PP VCD, with no differences in VCD success, vascular complications, or mortality. Therefore, selection of VCD for TAVR should be left to operator discretion, taking into account anatomical considerations.